GB9517701D0 - Method for treating hyperlipidemia - Google Patents
Method for treating hyperlipidemiaInfo
- Publication number
- GB9517701D0 GB9517701D0 GBGB9517701.0A GB9517701A GB9517701D0 GB 9517701 D0 GB9517701 D0 GB 9517701D0 GB 9517701 A GB9517701 A GB 9517701A GB 9517701 D0 GB9517701 D0 GB 9517701D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- treating hyperlipidemia
- hyperlipidemia
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30214994A | 1994-09-08 | 1994-09-08 |
Publications (2)
Publication Number | Publication Date |
---|---|
GB9517701D0 true GB9517701D0 (en) | 1995-11-01 |
GB2292885A GB2292885A (en) | 1996-03-13 |
Family
ID=23166467
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB9517701A Withdrawn GB2292885A (en) | 1994-09-08 | 1995-08-30 | Method of treating hyperlipidemia |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2292885A (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999004815A1 (en) | 1997-07-24 | 1999-02-04 | Yamanouchi Pharmaceutical Co., Ltd. | Medicinal compositions with cholesterol-lowering effect |
US20010006644A1 (en) * | 1997-07-31 | 2001-07-05 | David J. Bova | Combinations of hmg-coa reductase inhibitors and nicotinic acid and methods for treating hyperlipidemia once a day at night |
DE10134603A1 (en) * | 2001-07-17 | 2003-02-06 | Beiersdorf Ag | Cosmetic or dermatological preparations with a long-lasting cooling effect |
JP4870464B2 (en) * | 2001-07-17 | 2012-02-08 | 帝人株式会社 | Method for selecting substance and drug characterized by measuring PPARδ activation action |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2265376A (en) * | 1992-03-24 | 1993-09-29 | Merck & Co Inc | Human steroid hormone receptor (nuci) |
-
1995
- 1995-08-30 GB GB9517701A patent/GB2292885A/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
GB2292885A (en) | 1996-03-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2286825B (en) | Garbage treating apparatus | |
ZA959168B (en) | Method for treating anxiety | |
HU9602482D0 (en) | Method for treating 5ht2b receptor related conditions | |
AP9500762A0 (en) | Method for treating solid waste | |
ZA952022B (en) | Method for treating 5HT2B receptor related conditions | |
IL126759A0 (en) | Method for treating inflammation | |
IL125031A0 (en) | Method for treating depression | |
GB2289946B (en) | Method | |
HU9503330D0 (en) | Process for treating sewage | |
IL124786A0 (en) | Method for treating pain | |
GB9517701D0 (en) | Method for treating hyperlipidemia | |
EP0769904A4 (en) | Method for treating anxiety | |
ZA971899B (en) | Method for treating insomnia | |
EP0783304A4 (en) | Method for treating anxiety | |
GB9501400D0 (en) | Method for treating water | |
AP9701121A0 (en) | Method for prearing streptogramines | |
AU3662895A (en) | Method for treating animals | |
KR970006505B1 (en) | Waste treatment method | |
IL126160A0 (en) | Method for treating insomnia | |
HU9401012D0 (en) | Method for treating liquids | |
GB9401566D0 (en) | Method | |
TW333106U (en) | Garbage treating apparatus | |
IL121222A0 (en) | Method for treating 5HT2b receptor related conditions | |
GB9606731D0 (en) | Method for treating insomnia | |
KR0107856Y1 (en) | Setting apparatus for segment treating |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |